Our CEO, Dr Tim Oldham, spoke recently with Boardroom Broadcasts to discuss our unique i-body technology and our upcoming Phase I clinical trials for our lead candidate AD-214. Listen to it here
Our CEO, Dr Tim Oldham, spoke recently with Boardroom Broadcasts to discuss our unique i-body technology and our upcoming Phase I clinical trials for our lead candidate AD-214. Listen to it here